Banco BTG Pactual’s Cidara Therapeutics CDTX Stock Holding History

Banco BTG Pactual’s Portfolio CDTX Stock Details CDTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-1,136	Closed	-$251K	–	212
2025 Q4	$251K	Buy	+1,136	New	+$184K	0.04%	135

Banco BTG Pactual's CDTX Position: Q1 2026 in Review

Banco BTG Pactual sold out of Cidara Therapeutics (CDTX) in Q1 2026, closing a stake of 1,136 shares — an estimated $251K sold.

Banco BTG Pactual first reported a position in CDTX in Q4 2025 and held it in 1 quarter. The position peaked at $251K in Q4 2025. 0 funds tracked by Wall St. Rank hold CDTX as of Q1 2026.

Banco BTG Pactual reported no remaining Cidara Therapeutics position as of Q1 2026 after selling out during the quarter.
Banco BTG Pactual sold 1,136 Cidara Therapeutics shares in Q1 2026, an estimated $251K.
Banco BTG Pactual first reported a position in Cidara Therapeutics in Q4 2025 and held it in 1 quarter.
Banco BTG Pactual's Cidara Therapeutics position peaked at $251K in Q4 2025.
0 funds tracked by Wall St. Rank held Cidara Therapeutics as of Q1 2026.

Based on Banco BTG Pactual's 13F filing for Q1 2026, filed 13 May 2026.